July 10, 2017 6:00pm
Be ready for more “up downs”
The IBB was down -0.81%, XBI -1.50%, XLV -0.19%, IWM -0.43% while the VIX was down -0.71%,
Pre-open indication: seven (7) with 5 hits and 2 misses
Out and about: Cesca Therapeutics (KOOL) is acquiring SynGen Inc., a Sacramento-based developer of cellular processing technology. Under the deal, SynGen's assets will be folded into KOOL’s subsidiary Thermogenesis Corp.
I answer one question, in which company should investors commit and keep their money.
Monday’s results have implications to Tuesday’s sector activity.
A daily report may say little or a lot and its final judgement may be inconclusive; yet it serves as insurance that all indications are being examined and evaluated.
The advance/decline line scenario of 43 SCGT & RT covered companies:
· The open was negative with an A/DL of 12/27 and 4 flats;
· The mid-day was negative with an A/DL of 10/29 and 4 flats;
· The close was negative with an A/DL of 11/29 and 3 flats;
Pre-open indication: seven (7) - 5 hits and 2 misses
- Aduro Biotech (ADRO) closed down -$0.10 – hit;
- BioLife Solutions (BLFS) closed up +$0.02 – miss;
- Biostage (BSTG) closed up +$0.0137 – miss;
- Cellectis SA (CLLS) closed up +$0.64 – hit;
- Neuralstem (CUR) closed down -$0.12 – hit;
- Pluristem (PSTI) closed up +$0.02 – hit;
- Verastem (VSTM) closed down -$0.17 – hit;
Henry’omics:
From the pre-open’s investor’s newsletter …” what will today bring …”
- Reiterating, “The question is the same, what’s actionable?”
The sector got slammed to the mat after Friday’s “raised gloves” of a one round victory close.
Traders are getting ready for Q2 results which are being prepared … the sector NEEDS some catalysts but, what will matter are spending and cash positions as most development “plays” have been announced.
… Athersys (ATHX) will start the reporting on 8/9/17 …
Volume was split with up and downside pricing – there was NO clear metric to view.
If you are going to buy any of the sector stocks- you are going to need a bike helmet to modify or protect your portfolio from … other drivers (ETFs and algorithms> or factors
Be ready for another flip of the coin day …!
Out and about:
Cesca Therapeutics (KOOL) is acquiring SynGen Inc., a Sacramento-based developer of cellular processing technology. Under the deal, SynGen's assets will be folded into KOOL’s subsidiary Thermogenesis Corp.
- SynGen shareholders will receive $1 M in cash and 20% of ThermoGenesis's common stock.
The move indicates KOOL's interest in bolstering its regenerative medicine device division. Leading up to the acquisition, Cesca transferred its blood and bone marrow device assets to ThermoGenesis, which will now function as Cesca's primary device business.
- The stock market reacted positively to the deal, with KOOL shares closed up +$0.55, or 16.92%, to $3.80.
Daily analytics:
The NASDAQ and the S&P 500 finished higher Monday while the Dow closed fractionally lower.
The Dow (-0.03%) after clinging to modest gains over the session, finished with a loss of 5.82 points, or less than 0.1%, at 21,408.52.
The S&P 500 index SPX (+0.09%) advanced 2.25 points, or 0.1%, to close at 2,427.43. Meanwhile, the Nasdaq Composite Index COMP, +0.38% was the session’s best performing benchmark, closing up 23.31 points, or 0.4%, to 6,176.39.
… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 11.11, down -0.71% …
Welcome to another day of the sector’s roller coaster …
… The iShares Russell 2000 (IWM) indicated:
· Monday’s down -0.43%
… The iShares NASDAQ Biotechnology (IBB) indicated:
· Monday’s down -0.81%
The count - decliners versus gainers:
……. look at the differences in the spreads as decliners jump and %’s migrate……….
· Monday’s decliners ranged from -0.25% <RGNX> to -23.57% <IMUC> in 29 equities
Versus
………… look at the percentage’s (%) and their decreases …….
· Monday’s gainers ranged from +0.67% <BCLI> to +16.92% <KOOL> in 11 equities;
Some of MY working trend lines or indications:
… The greatest volume to the downside: VSTM, BLUE, KITE, JUNO and ATHX
… Upside volume was weighted to: KOOL, BSTG, CYTX, VTGN and PSTI
… Biggest $ downside: BLUE, KITE, ONCE, JUNO and XON
… Largest $ upside: CLLS, KOOL, VTGN, QURE and BCLI
… Flat: NWBO, ISCO and CAPR
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
